Skip to content

Organosilane for Surface Cleaning in Intensive Care Units

Organosilane for Surface Cleaning in Intensive Care Units: A Cluster Randomized, Controlled, Crossover, Clinical Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05673226
Acronym
ORG-CLEAN
Enrollment
10301
Registered
2023-01-06
Start date
2023-11-06
Completion date
2025-01-30
Last updated
2025-09-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infection, Hospital

Keywords

Infection Control, Infections, Intensive Care Units, Pneumonia, Ventilator Associated, Catheter-Related Infections, Urinary Tract Infections, Organosilanes, Costs and Cost Analyses

Brief summary

The purpose of this study is to evaluate if surface disinfection with organosilane associated with traditional cleaning reduces the incidence of healthcare-associated infections (HAIs) in intensive care units when compared with traditional cleaning alone.

Interventions

OTHERSurface disinfection with Organosilane

Organosilane will be sprayed on the surfaces, using an atomizer. When the environment has been completely covered (i.e., when all surfaces and equipment have a slightly damp film), we will proceed with the second phase of the disinfection of all heavily touched surfaces. surfaces of the bed, with a microfiber cloth with organosilane.

Sponsors

Hospital Sirio-Libanes
CollaboratorOTHER
Hospital Moinhos de Vento
CollaboratorOTHER
Hospital Alemão Oswaldo Cruz
CollaboratorOTHER
Hospital do Coracao
CollaboratorOTHER
Beneficência Portuguesa de São Paulo
CollaboratorOTHER
Hospital Israelita Albert Einstein
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Outcomes Assessor)

Intervention model description

Randomized, controlled, cluster, crossover, trial

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* All patients aged 18 years and older who will be admitted to the participating ICUs

Exclusion criteria

* Patients under 18 years * ICUs that may use any organosilane formulation for surface disinfection

Design outcomes

Primary

MeasureTime frame
Incidence of healthcare associated infections6 months

Secondary

MeasureTime frameDescription
Contamination of environmental surfaces by multi-resistant microorganisms6 monthsWe will collect environmental samples from 4 surfaces highly touched by the patient, health team and family (bed rails, monitor and infusion pump buttons, meal table or procedure table, and IV drip stand) before and after the intervention. (end of the 6 months). For analysis of the environmental samples, characterization of the density and microbiological profile of biofilms on the different surfaces of the ICU beds will be performed using large-scale DNA sequencing techniques associated with bioinformatics analysis.
Incidence of ventilator-associated pneumonia6 months
Incidence of central line-associated blood stream infections6 months
Incidence of catheter-associated urinary tract infection6 months
Intensive care unit length of stay costs6 months

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026